
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Can you identify these 4 lesions seen in a primary care setting? Should biopsy be performed on any? All? Test your visual diagnostic skills.
Have a look at these 4 lesions seen in a primary care setting. Would any concern you? Which would you consider for biopsy? Test your visual diagnostic skills with a short quiz.